DANOCRINE Detail

Drug Name(s):
DANOCRINE

FDA Application No.:
NDA 017557

Active Ingredient(s):
DANAZOL

Company:
SANOFI AVENTIS US

Original Approval or Tentative Approval Date:
September 26, 1976

Products on Application NDA 017557:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
DANAZOL	100MG	CAPSULE; ORAL	Discontinued	none
DANAZOL	200MG	CAPSULE; ORAL	Discontinued	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	November 2008
S	M	T	W	T	F	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Who's online

There are currently 0 users and 432 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 11-21-2008

Links to Site